Stanton K - Search Results

1

Improvement in endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus.

O'Driscoll G, Green D, Maiorana A, Stanton K, Colreavy F, Taylor R. O'Driscoll G, et al. Among authors: stanton k. J Am Coll Cardiol. 1999 May;33(6):1506-11. doi: 10.1016/s0735-1097(99)00065-0. J Am Coll Cardiol. 1999. PMID: 10334415 Clinical Trial.

2

Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria.

Dogra GK, Watts GF, Chan DC, Stanton K. Dogra GK, et al. Among authors: stanton k. Diabet Med. 2005 Mar;22(3):239-42. doi: 10.1111/j.1464-5491.2004.01382.x. Diabet Med. 2005. PMID: 15717868 Clinical Trial.

3

The effect of combined aerobic and resistance exercise training on vascular function in type 2 diabetes.

Maiorana A, O'Driscoll G, Cheetham C, Dembo L, Stanton K, Goodman C, Taylor R, Green D. Maiorana A, et al. Among authors: stanton k. J Am Coll Cardiol. 2001 Sep;38(3):860-6. doi: 10.1016/s0735-1097(01)01439-5. J Am Coll Cardiol. 2001. PMID: 11527646 Clinical Trial.

4

Losartan, an angiotensin type I receptor antagonist, improves conduit vessel endothelial function in Type II diabetes.

Cheetham C, O'Driscoll G, Stanton K, Taylor R, Green D. Cheetham C, et al. Among authors: stanton k. Clin Sci (Lond). 2001 Jan;100(1):13-7. Clin Sci (Lond). 2001. PMID: 11115412 Clinical Trial.

5

Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes.

Cheetham C, Collis J, O'Driscoll G, Stanton K, Taylor R, Green D. Cheetham C, et al. Among authors: stanton k. J Am Coll Cardiol. 2000 Nov 1;36(5):1461-6. doi: 10.1016/s0735-1097(00)00933-5. J Am Coll Cardiol. 2000. PMID: 11079643 Clinical Trial.

6

Losartan, an angiotensin type 1 receptor inhibitor, and endothelial vasodilator function in Type 1 diabetes mellitus.

Collis J, Cheetham C, Dembo L, O'Driscoll J, Stanton K, Taylor R, Green D. Collis J, et al. Among authors: stanton k. Diabet Med. 2000 Jul;17(7):553-4. doi: 10.1046/j.1464-5491.2000.00311-4.x. Diabet Med. 2000. PMID: 10972591 Clinical Trial. No abstract available.

7

Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus.

O'Driscoll G, Green D, Rankin J, Stanton K, Taylor R. O'Driscoll G, et al. Among authors: stanton k. J Clin Invest. 1997 Aug 1;100(3):678-84. doi: 10.1172/JCI119580. J Clin Invest. 1997. PMID: 9239416 Free PMC article.

8

Homocysteine, folate, methylene tetrahydrofolate reductase genotype and vascular morbidity in diabetic subjects.

Kaye JM, Stanton KG, McCann VJ, Vasikaran SD, Burke V, Taylor RR, van Bockxmeer FM. Kaye JM, et al. Clin Sci (Lond). 2002 Jun;102(6):631-7. Clin Sci (Lond). 2002. PMID: 12049616

9

Effect of lowering tumour necrosis factor-alpha on vascular endothelial function in Type II diabetes.

Bilsborough W, O'Driscoll G, Stanton K, Weerasooriya R, Dembo L, Taylor R, Green D. Bilsborough W, et al. Among authors: stanton k. Clin Sci (Lond). 2002 Aug;103(2):163-9. doi: 10.1042/cs1030163. Clin Sci (Lond). 2002. PMID: 12149108 Clinical Trial.

10

Microalbuminuria in type 2 diabetes: an independent predictor of cardiovascular mortality.

Beilin J, Stanton KG, McCann VJ, Knuiman MW, Divitini ML. Beilin J, et al. Among authors: stanton kg. Aust N Z J Med. 1996 Aug;26(4):519-25. doi: 10.1111/j.1445-5994.1996.tb00598.x. Aust N Z J Med. 1996. PMID: 8873935

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results